Chimerix, Inc.

317 articles about Chimerix, Inc.

• Chimerix to Announce Third Quarter 2017 Financial Results on November 8, 2017

  11/1/2017

  An archived webcast will be available on the Chimerix website approximately two hours after the event.

• Chimerix Appoints Heather Knight-Trent, PharmD, As Vice President Of Regulatory Affairs

  9/12/2017

• Chimerix Announces Second Quarter 2017 Financial Results

  8/7/2017

• Chimerix To Announce Second Quarter 2017 Financial Results On August 7, 2017

  7/31/2017

• Chimerix Announces First Quarter 2017 Financial Results

  5/9/2017

• Chimerix To Announce First Quarter 2017 Financial Results On May 9, 2017

  5/2/2017

• Chimerix To Host Annual Investor Update On April 27, 2017

  4/20/2017

• Chimerix Announces Fourth Quarter And Full Year 2016 Financial Results

  3/2/2017

• Chimerix To Announce Fourth Quarter And Full Year 2016 Financial Results On March 2, 2017

  2/23/2017

• Chimerix Announces Final Data From Advise Trial Of Brincidofovir At BMT Tandem Meetings

  2/22/2017

• Chimerix Announces Preliminary Data From Ongoing Phase I Dose Escalation Study Of Intravenous Brincidofovir In Healthy Subjects

  1/6/2017

• Chimerix Presents Data From A Preclinical Study Of Intravenous Brincidofovir At AAPS

  11/18/2016

• Chimerix To Announce Third Quarter 2016 Financial Results On November 7, 2016

  10/31/2016

• Chimerix Announces Presentation At IDWeek Of Detailed 24-Week Results From Advise Trial Of Brincidofovir For The Treatment Of Adenovirus Infection In Allogeneic Hematopoietic Cell Transplant Recipients

  10/28/2016

• Alzheimer's Biotech Cognition Therapeutics Taps Chimerix-Alteon Vet as New CEO

  10/28/2016

• Chimerix To Present At The Morgan Stanley Global Healthcare Conference

  9/6/2016

• Chimerix Announces Second Quarter 2016 Financial Results

  8/8/2016

• Chimerix To Announce Second Quarter 2016 Financial Results On August 8, 2016

  8/1/2016

• More Bad News for Chimerix as Brincidofovir Fails Another Late Stage Study

  5/9/2016

• North Carolina Biotechs Like Chimerix, Heat Biologics Desperately Seek Funding in Down Market

  3/28/2016